Eterna Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Eterna Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Eterna Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 5.41M shares, a 0.02% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.41M +1K +0.02% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 5.41M +283K +5.52% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 5.41M +283K +5.52% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 5.41M +2.47M +83.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 5.41M -52.1M -90.6% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 5.13M -52.3M -91.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 5.13M +2.53M +97.1% Dec 31, 2022 10-K 2024-03-14
Q3 2022 2.94M -49.1M -94.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 57.5M +12.8M +28.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 57.5M +15.9M +38.4% Mar 31, 2022 10-Q 2022-07-01
Q4 2021 2.6M +2.6M Dec 31, 2021 10-K 2023-03-20
Q3 2021 52M +49.1M +1663% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 44.7M +41.8M +1422% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 41.5M +38.6M +1319% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 0 -2.9M -100% Dec 31, 2020 10-K/A 2022-07-01
Q3 2020 2.95M +57K +1.97% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 2.94M +56K +1.94% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 2.93M +48K +1.67% Mar 31, 2020 10-Q 2020-05-20
Q4 2019 2.9M +26K +0.9% Dec 31, 2019 10-K 2021-03-11
Q3 2019 2.9M +23K +0.8% Sep 30, 2019 10-Q 2019-11-01
Q2 2019 2.88M +16K +0.56% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 2.88M +357K +14.2% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 2.88M +354K +14% Dec 31, 2018 10-K 2020-03-19
Q3 2018 2.87M +356K +14.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 2.87M +353K +14% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 2.52M +37K +1.49% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 2.52M +260K +11.5% Dec 31, 2017 10-K 2019-03-22
Q3 2017 2.52M +667K +36.1% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 2.51M +664K +35.9% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 2.48M -90M -97.3% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 2.26M +412K +22.3% Dec 31, 2016 10-K 2018-03-09
Q3 2016 1.85M -90.6M -98% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 1.85M -90.6M -98% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 92.4M +58K +0.06% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 1.85M -90.5M -98% Dec 31, 2015 10-K 2017-03-09
Q3 2015 92.4M +118K +0.13% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 92.4M +749K +0.82% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 92.4M +13.7M +17.3% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 92.4M +13.7M +17.4% Dec 31, 2014 10-K 2016-03-15
Q3 2014 92.3M +92.2M +128492% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 91.7M +91.6M +127914% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 78.7M +78.7M +109977% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 78.6M +7.53M +10.6% Dec 31, 2013 10-K 2015-03-27
Q3 2013 71.8K +728 +1.03% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 71.6K +559 +0.79% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 71.5K +518 +0.73% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 71.1M +71.1M +116635% Dec 31, 2012 10-K 2014-03-31
Q3 2012 71K +10.1K +16.6% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 71K +10.2K +16.7% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 71K Mar 31, 2012 10-Q 2012-05-11
Q4 2011 60.9K +176 +0.29% Dec 31, 2011 10-K 2013-03-29
Q3 2011 60.9K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 60.9K Jun 30, 2011 10-Q 2011-08-12
Q4 2010 60.8K Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.